These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 5780882

  • 21. Lipids in brain tumors.
    Grossi-Paoletti E, Paoletti P, Fumagalli R.
    J Neurosurg; 1971 Mar; 34(3):454-5. PubMed ID: 4323146
    [No Abstract] [Full Text] [Related]

  • 22. Studies on the chemotherapy of experimental brain tumors: development of an experimental model.
    Ausman JI, Shapiro WR, Rall DP.
    Cancer Res; 1970 Sep; 30(9):2394-400. PubMed ID: 5475483
    [No Abstract] [Full Text] [Related]

  • 23. [Metabolism of L-cystathione in tissue of brain glial tumors].
    Promyslov MSh, Sokovnina IaM, Iurkina NA.
    Vopr Med Khim; 1973 Sep; 19(6):622-4. PubMed ID: 4369616
    [No Abstract] [Full Text] [Related]

  • 24. Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
    Sie M, den Dunnen WF, Lourens HJ, Meeuwsen-de Boer TG, Scherpen FJ, Zomerman WW, Kampen KR, Hoving EW, de Bont ES.
    PLoS One; 2015 Sep; 10(3):e0122555. PubMed ID: 25799134
    [Abstract] [Full Text] [Related]

  • 25. Oxidative metabolism of brain tumors.
    Allen N.
    Prog Exp Tumor Res; 1972 Sep; 17():192-209. PubMed ID: 4344743
    [No Abstract] [Full Text] [Related]

  • 26. Energy metabolism of glial tumors.
    Lehrer GM, Maker HS.
    J Neurosurg; 1971 Mar; 34(3):452-3. PubMed ID: 5547328
    [No Abstract] [Full Text] [Related]

  • 27. [The composition of the fluid of cystic brain tumors of different histological nature].
    Burgman GP, Lobkova TN.
    Vopr Neirokhir; 1970 Mar; 34(3):47-50. PubMed ID: 4319487
    [No Abstract] [Full Text] [Related]

  • 28. EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.
    Antin C, Tauziède-Espariat A, Debily MA, Castel D, Grill J, Pagès M, Ayrault O, Chrétien F, Gareton A, Andreiuolo F, Lechapt E, Varlet P.
    Acta Neuropathol Commun; 2020 Nov 05; 8(1):183. PubMed ID: 33153494
    [No Abstract] [Full Text] [Related]

  • 29. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA, Crafts DC, Wilson CB, Schultz MJ, Boldrey EB, Enot KJ, Pischer TL, Seager M, Elashoff RM.
    Cancer Treat Rep; 1976 Mar 05; 60(3):243-9. PubMed ID: 177210
    [Abstract] [Full Text] [Related]

  • 30. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS.
    Ugeskr Laeger; 2006 Nov 20; 168(47):4082-5. PubMed ID: 17134603
    [Abstract] [Full Text] [Related]

  • 31. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y, Zhang YX.
    Acta Cytol; 1989 Nov 20; 33(6):922-8. PubMed ID: 2588925
    [Abstract] [Full Text] [Related]

  • 32. Metabolic changes in cerebral gliomas within hours of treatment with intra-arterial BCNU demonstrated by phosphorus magnetic resonance spectroscopy.
    Arnold DL, Shoubridge EA, Feindel W, Villemure JG.
    Can J Neurol Sci; 1987 Nov 20; 14(4):570-5. PubMed ID: 3690427
    [Abstract] [Full Text] [Related]

  • 33. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR, Ausman JI, Rall DP.
    Cancer Res; 1970 Sep 20; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract] [Full Text] [Related]

  • 34. An immunological study of human brain tumors concerning the brain specific protein S-100 and 14.3.2.
    Haglid K, Carlsson CA, Stavrou D.
    Acta Neuropathol; 1973 May 16; 24(3):187-96. PubMed ID: 4357170
    [No Abstract] [Full Text] [Related]

  • 35. [Chemotherapy of brain tumors].
    Takeuchi K.
    Naika; 1968 Sep 16; 22(3):693-701. PubMed ID: 4303516
    [No Abstract] [Full Text] [Related]

  • 36. The S-100 protein in rat brain and in methylnitrosourea-induced tumors of the rat nervous system. A quantitative study.
    Stavrou D, Haglid KG, Rönnbäck L.
    Eur Neurol; 1973 Sep 16; 10(3):168-78. PubMed ID: 4761599
    [No Abstract] [Full Text] [Related]

  • 37. The development of an intracerebral glioma model for brain tumor chemotherapy.
    Wassenaar W, Tator CH, So WS.
    J Neurosurg; 1973 Sep 16; 39(3):293-301. PubMed ID: 4582100
    [No Abstract] [Full Text] [Related]

  • 38. [EXPERIMENTAL STUDY OF BRAIN NEOPLASMS].
    KAWAI S.
    Nihon Byori Gakkai Kaishi; 1963 Sep 16; 52():59-82. PubMed ID: 14200993
    [No Abstract] [Full Text] [Related]

  • 39. Chemotherapy of primary brain tumors.
    Levin VA.
    Neurol Clin; 1985 Nov 16; 3(4):855-66. PubMed ID: 3001491
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.